Novartis | NVS - Market Capitalization


Novartis reported $314.84B in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 403.83B 5.2B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
AstraZeneca USD 288.15B 55.08B Dec/2025
Bausch Health Companies USD 2.58B 194.9M Dec/2025
Biogen USD 25.82B 5.28B Dec/2025
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Canopy Growth CAD 656.46M 124.89M Dec/2025
Corcept Therapeutics USD 3.66B 5.1B Dec/2025
Drreddys Laboratories INR 11.69B 50M Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Glaxosmithkline GBP 99.93B 13.05B Dec/2025
J&J USD 500.24B 67.44B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Novartis USD 292.21B 26.55B Dec/2025
Novartis USD 263.08B 17.01B Dec/2025
Pacira USD 1.06B 94M Dec/2025
Perrigo USD 1.92B 1.04B Dec/2025
Pfizer USD 141.57B 6.48B Dec/2025
Phibro Animal Health USD 1.51B 126M Dec/2025
Prestige Brands USD 2.97B 105M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
Sanofi EUR 117.34B 2.45B Dec/2025
Supernus Pharmaceuticals USD 2.85B 151M Dec/2025
Zoetis USD 55.45B 9.4B Dec/2025